Roukounas, Dimitrios Analysis

LAW FIRM ANALYSIS

Latest European patent oppositions filed by Roukounas, Dimitrios

Patent:
Title:
S1P Receptor Modulators For Treating Multiple Sclerosis
Applicant:
Opposition Date:
2022-11-04
Patent:
Title:
S1P Receptor Modulators For Treating Multiple Sclerosis
Applicant:
Opposition Date:
2022-10-20
Patent:
Title:
Aqueous Pharmaceutical Formulation Of Tapentadol For Oral Administration
Opposition Date:
2021-01-22

Top clients of Roukounas, Dimitrios filing patent oppositions